11. Conclusion
This study outlines the various stages involved in the discovery and development of a new active ingredient. Subsequently, and with a view to submitting a marketing authorization application for a drug (MA), the corresponding pharmaco-toxicological, clinical and pharmaceutical files must be supplied.
The pharmaceutical dossier includes a description of the preparation method, requiring the use of various industrial processes ranging from extraction to hemisynthesis or total synthesis. The choice of method generally depends on its cost price.
On the other hand, as long as the conformity of an active ingredient with the standards set by the pharmacopoeia or by the manufacturer has not been established, the active ingredient is not retained for pharmaceutical formulation, hence the importance of drug testing.
First,...
Exclusive to subscribers. 97% yet to be discovered!
You do not have access to this resource.
Click here to request your free trial access!
Already subscribed? Log in!
The Ultimate Scientific and Technical Reference
This article is included in
Drugs and pharmaceuticals
This offer includes:
Knowledge Base
Updated and enriched with articles validated by our scientific committees
Services
A set of exclusive tools to complement the resources
Practical Path
Operational and didactic, to guarantee the acquisition of transversal skills
Doc & Quiz
Interactive articles with quizzes, for constructive reading
Conclusion
References
Books dealing with the structure and/or preparation, therapeutic indications of drugs or active ingredients:
Exclusive to subscribers. 97% yet to be discovered!
You do not have access to this resource.
Click here to request your free trial access!
Already subscribed? Log in!
The Ultimate Scientific and Technical Reference